- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01917500
Feasibility Study of Non-invasive and Continuous Measurement of Blood Pressure and Cardiac Output: Comparison to Non-invasive and Non-continuous Measurements
The objectives of this clinical trial is to validate a S/W application to compare the calculations of Hemodynamic parameters like Continuous blood pressure (BP) and Continuous cardiac output (CO). This Hemodynamic parameters are computed from Pulse Oximeter (PhotoPlethysmograph or PPG) signal with results obtained by NIBP intermittent measurements and Echocardiography. The first phase of the study will be done on 10 patients of the Cardiology dept.- Cardiac ICU, that have routine measurements of BP and CO using Echocardiography.
The HeartBeat system combines an FDA/CE approved watch-like Pulse Oximeter for acquiring the data and a Smartphone S/W application that serves as the Hemodynamic calculator. The S/W application performs POST-PROCESSING of the PhotoPlethismoGraphic (PPG) signal (Normally the PPG signal in Pulse Oximeters is used only to compute heart rate and SpO2). The raw data is transferred from the watch oximeter to the smartphone using a standard Bluetooth protocol.
The Post-processing uses wavelet signal processing to estimate and display certain Hemodynamic parameters like (Blood Pressure) BP and CO in a continuous and graphical way on a standard Android Smartphone. In addition to the standard heart rate and SpO2, the application displays the measured PPG signal and estimated continues BP and CO.
HeartBeat is the only device that can non-invasively estimate Continuous BP and its Cardiac Output component and the resistance component in a mobile wearable device. Differentiating between these 2 components can play a major role in helping the doctor to understand the effect of cardiovascular medications and Lifestyle interventions.
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Haifa, Israel
- Rambam Health Care Campus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male and females
- Between the ages of 20-70 years old
Exclusion Criteria:
- Over 70 years old
- under 20 years old
- Supportive blood pressure
- Severe Sepsis
- Ventilated patients
- Supported by Amines
- Patients in state of Shock
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
Cohorts and Interventions
Group / Cohort |
|---|
|
Cardiac ward 10 patients
10 patients from the cardiac ward.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiac Output
Time Frame: 1 month
|
Patients in the cardiac department pass an echo-cardiograph procedure to measure their cardiac output. When it is done, we will attach our oximeter to the patient and using the application we will calculate Cardiac Output. We will compare between both measurements |
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood Pressure
Time Frame: 1 month
|
Patients in the cardiac department have their blood pressure often measured . When it is done, we will attach our oximeter to the patient and using the application we will calculate our blood pressure. We will compare between both measurements |
1 month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HeartBeat_V1.0
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart or Vascular Disease
-
BayerCompleted
-
Universitaire Ziekenhuizen KU LeuvenCompletedPulmonary Vascular DiseaseBelgium
-
Centre Hospitalier Universitaire de BesanconCompletedVascular Diseases | Cardiovascular Abnormalities | Retinal VascularFrance
-
University Medical Center GroningenRecruitingCongenital Heart Disease | Fontan Operation | Pulmonary Vascular Resistance | Pulmonary Vascular RemodelingNetherlands
-
Universitaire Ziekenhuizen KU LeuvenCompletedHeart Septal Defects, AtrialBelgium
-
BayerCompletedPeripheral Vascular Diseases | Peripheral Arterial Diseases | Magnetic Resonance AngiographyJapan
-
Hillel Yaffe Medical CenterUnknown
-
Bracco Diagnostics, IncCompletedCarotid, Aortic, Renal or Peripheral Artery DiseaseChina
-
Forest LaboratoriesTerminatedIschemic Heart Disease | Heart DiseaseUnited States